Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)

Kate Lynn, J. Bill, Jeannine Garnett, Isabelle Meaux, Xiao Yen Ma, Chad J. Creighton, Svetlana Bolshakov, Cedric Barriere, Laurent Debussche, Alexander J. Lazar, Bethany C. Prudner, Lucia Casadei, Danielle Braggio, Gonzalo Lopez, Abbie Zewdu, Hemant Bid, Lev Dina, Raphael E. Pollock

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)'. Together they form a unique fingerprint.

Medicine & Life Sciences